dc.contributor.author |
Filippi, Luca
|
|
dc.contributor.author |
Evangelista, Laura
|
|
dc.contributor.author |
Sathekge, Mike Machaba
|
|
dc.contributor.author |
Schillaci, Orazio
|
|
dc.date.accessioned |
2023-06-09T07:02:04Z |
|
dc.date.issued |
2022-12 |
|
dc.description.abstract |
Please read abstract in the article. |
en_US |
dc.description.department |
Nuclear Medicine |
en_US |
dc.description.embargo |
2023-08-21 |
|
dc.description.librarian |
hj2023 |
en_US |
dc.description.uri |
https://link.springer.com/journal/40336 |
en_US |
dc.identifier.citation |
Filippi, L., Evangelista, L., Sathekge, M.M. et al. ImmunoPET for prostate cancer in the PSMA era: do we need other targets? Clinical and Translational Imaging 10, 587–596 (2022). https://doi.org/10.1007/s40336-022-00520-w. |
en_US |
dc.identifier.issn |
2281-5872 (print) |
|
dc.identifier.issn |
2281-7565 (online) |
|
dc.identifier.other |
10.1007/s40336-022-00520-w |
|
dc.identifier.uri |
http://hdl.handle.net/2263/91067 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Springer |
en_US |
dc.rights |
© The Author(s), under exclusive licence to Italian Association of Nuclear Medicine and Molecular Imaging 2022. The original publication is available at http://link.springer.com/journal/40336 [12 months embargo] |
en_US |
dc.subject |
Prostate stem cell antigen (PSCA) |
en_US |
dc.subject |
Metastatic castration-resistant PC (mCRPC) |
en_US |
dc.subject |
Prostate specific membrane antigen (PSMA) |
en_US |
dc.subject |
Prostate cancer |
en_US |
dc.subject |
ImmunoPET |
en_US |
dc.subject |
Precision medicine |
en_US |
dc.subject |
Positron emission tomography/computed tomography (PET/CT) |
en_US |
dc.subject |
Castration-resistant prostate cancer |
en_US |
dc.subject |
Theranostics |
en_US |
dc.subject |
SDG-03: Good health and well-being |
en_US |
dc.title |
ImmunoPET for prostate cancer in the PSMA era : do we need other targets? |
en_US |
dc.type |
Postprint Article |
en_US |